We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

70 hedge funds and large institutions have $1.3B invested in Cullinan Oncology in 2021 Q1 according to their latest regulatory filings, with 70 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

75.66% more ownership

Funds ownership: 0% → 75.66% (+76%)

Holders
70
Holders Change
+70
Holders Change %
–
% of All Funds
1.23%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.07%
New
70
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MB
MPM BioImpact
Massachusetts
+$321M
2
FCMV
Foresite Capital Management V
California
+$111M
3
CA
CHI Advisors
New York
+$89.4M
4
BG
Baupost Group
Massachusetts
+$74.5M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$49.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$358K +$348K +8,582 New
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$350K +$341K +8,400 New
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$308K +$300K +7,382 New
PNC Financial Services Group
54
PNC Financial Services Group
Pennsylvania
$306K +$299K +7,356 New
MIM
55
MetLife Investment Management
New Jersey
$254K +$248K +6,098 New
VOYA Investment Management
56
VOYA Investment Management
Georgia
$228K +$222K +5,466 New
Ensign Peak Advisors
57
Ensign Peak Advisors
Utah
$208K +$203K +5,000 New
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
$186K +$181K +4,457 New
Wells Fargo
59
Wells Fargo
California
$171K +$166K +4,095 New
SO
60
STRS Ohio
Ohio
$133K +$130K +3,200 New
UBS Group
61
UBS Group
Switzerland
$129K +$126K +3,093 New
Citigroup
62
Citigroup
New York
$103K +$100K +2,470 New
Legal & General Group
63
Legal & General Group
United Kingdom
$56K +$55K +1,355 New
Royal Bank of Canada
64
Royal Bank of Canada
Ontario, Canada
$52K +$51.1K +1,258 New
AIP
65
Ameritas Investment Partners
Nebraska
$45K +$43.4K +1,068 New
IC
66
Ikarian Capital
Texas
$42K +$40.6K +1,000 New
TRCT
67
Tower Research Capital (TRC)
New York
$34K +$33.3K +820 New
Morgan Stanley
68
Morgan Stanley
New York
$16K +$15.6K +385 New
Bank of Montreal
69
Bank of Montreal
Ontario, Canada
$14K +$16.2K +399 New
AIG
70
American International Group
New York
$319 +$311K +7,650 New
1 2
3

CGEM Hedge Fund Activity: Q1 2021 in Review

70 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q1 2021, worth a combined $1.3B.

Buyers outnumbered sellers: 70 funds opened new CGEM positions and 0 closed out — a net gain of 70 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was MPM BioImpact, opening a new position worth an estimated $321M.

  • 70 institutional investors held Cullinan Oncology (CGEM) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $1.3B of Cullinan Oncology stock for Q1 2021.
  • 70 funds opened new Cullinan Oncology positions in Q1 2021 and 0 closed out, a net change of +70 holders.
  • The largest Cullinan Oncology buyer in Q1 2021 was MPM BioImpact, an estimated $321M added.

Based on aggregated 13F filings for Q1 2021.